Published in
Elsevier, The Lancet Oncology, 6(15), p. 656-666, 2014
DOI: 10.1016/s1470-2045(14)70155-x
Links
Tools
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
Journal article published in 2014 by
David S. Hong,
David Hui,
Eduardo Bruera,
Filip Janku,
Aung Naing,
Gerald S. Falchook,
Sarina Piha-Paul 
,
Jennifer J. Wheler,
Siqing Fu ,
Apostolia M. Tsimberidou,
Michael Stecher,
Prasant Mohanty,
John Simard,
Razelle Kurzrock
,
Jennifer J. Wheler,
Siqing Fu ,
Apostolia M. Tsimberidou,
Michael Stecher,
Prasant Mohanty,
John Simard,
Razelle Kurzrock
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 